Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $29.71 USD
Change Today 0.00 / 0.00%
Volume 483.8K
PODD On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 4:30 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

insulet corp (PODD) Snapshot

Open
$29.66
Previous Close
$29.71
Day High
$30.16
Day Low
$29.50
52 Week High
12/8/14 - $47.97
52 Week Low
05/1/15 - $24.95
Market Cap
1.7B
Average Volume 10 Days
537.6K
EPS TTM
$-0.66
Shares Outstanding
56.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INSULET CORP (PODD)

insulet corp (PODD) Related Bloomberg News

View More Bloomberg News

insulet corp (PODD) Related Businessweek News

No Related Businessweek News Found

insulet corp (PODD) Details

Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod, a disposable insulin infusion device that integrates an infusion set, automated cannula insertion, insulin reservoir, drive mechanism, and batteries; and personal diabetes manager, a handheld wireless device. It also sells blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells and markets its OmniPod System to diabetes practitioners, academic medical centers, clinics, people with insulin-dependent diabetes, third-party payors, and government agencies, as well as third-party distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.

519 Employees
Last Reported Date: 02/26/15
Founded in 2000

insulet corp (PODD) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $182.5K
Executive Vice President of Human Resources a...
Total Annual Compensation: $49.7K
Compensation as of Fiscal Year 2014.

insulet corp (PODD) Key Developments

Insulet Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Reaffirms Earnings Guidance for the Year Ending December 31, 2015; Provides Earnings Guidance for the Third Quarter of 2015

Insulet Corporation reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenue of $75,588,000 against $72,013,000 a year ago. Operating loss was $12,361,000 against $5,280,000 a year ago. This result was primarily driven by a 14% increase in operating expenses to $46.7 million compared with $41.0 million in the prior year. Loss before income taxes was $15,395,000 against $29,059,000 a year ago. Net loss was $15,432,000 or $0.27 per basic and diluted share against $29,111,000 or $0.53 per basic and diluted share a year ago. For the six months, the company reported revenue of $136,803,000 against $141,174,000 a year ago. Operating loss was $20,991,000 against $7,166,000 a year ago. Loss before income taxes was $27,177,000 against $35,138,000 a year ago. Net loss was $27,266,000 or $0.48 per basic and diluted share against $35,255,000 or $0.64 per basic and diluted share a year ago. For the year ending December 31, 2015, the company is reaffirming its revenue guidance of $305 to $320 million. For the third quarter of 2015, the company is expecting revenue to be in the range of $82 to $85 million.

Insulet Corporation to Report Q2, 2015 Sales/Trading Statement Results on Aug 12, 2015

Insulet Corporation announced that they will report Q2, 2015 sales/trading statement results at 5:00 PM, Eastern Standard Time on Aug 12, 2015

Insulet Corporation announced delayed 10-Q filing

On 08/10/2015, Insulet Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PODD:US $29.71 USD 0.00

PODD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $45.29 USD -0.73
DexCom Inc $94.14 USD -0.05
Smiths Group PLC 1,129 GBp +27.00
Takeda Pharmaceutical Co Ltd ¥5,962 JPY -4.00
Tandem Diabetes Care Inc $11.48 USD -0.22
View Industry Companies
 

Industry Analysis

PODD

Industry Average

Valuation PODD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.9x
Price/Book 24.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSULET CORP, please visit www.insulet.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.